Chugai Pharmaceutical Co., Ltd.
4519.T
7370
JPY-197.00
(-2.60%)Day's range
7370
7565
52 wk Range
4572
8655
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 786,946,000,000 | 999,759,000,000 | 1,259,946,000,000 | 1,111,367,000,000 | 1,170,611,000,000 | |
| Gross Profit | 513,481,000,000 | 661,612,000,000 | 783,695,000,000 | 698,061,000,000 | 831,202,000,000 | |
| Operating Income | 301,230,000,000 | 421,897,000,000 | 533,309,000,000 | 439,174,000,000 | 542,002,000,000 | |
| Net Income | 214,733,000,000 | 302,995,000,000 | 374,429,000,000 | 325,472,000,000 | 387,317,000,000 | |
| Total Assets | 1,235,498,000,000 | 1,538,694,000,000 | 1,869,758,000,000 | 1,932,547,000,000 | 2,208,373,000,000 | |
| Total Current Liabilities | 236,070,000,000 | 327,422,000,000 | 423,730,000,000 | 288,217,000,000 | 290,357,000,000 | |
| Total Equity | 980,003,000,000 | 1,188,017,000,000 | 1,424,387,000,000 | 1,625,580,000,000 | 1,901,499,000,000 | |
| Free Cash Flow | 143,624,000,000 | 206,760,000,000 | 172,873,000,000 | 335,667,000,000 | 396,675,000,000 | |
| Cash from Operations | 205,035,000,000 | 279,626,000,000 | 244,112,000,000 | 409,925,000,000 | 447,600,000,000 | |
| Cash from Investing | -98,312,000,000 | -118,927,000,000 | -145,994,000,000 | -37,290,000,000 | -227,365,000,000 | |
| Cash from Financing | -99,497,000,000 | -107,408,000,000 | -145,641,000,000 | -139,331,000,000 | -141,006,000,000 | |
| Net Change in Cash | 8,392,000,000 | 55,420,000,000 | -45,584,000,000 | 236,505,000,000 | 81,528,000,000 |